Dimensional Fund Advisors
JANX icon

Dimensional Fund Advisors’s Janux Therapeutics JANX Stock Holding History

Dimensional Fund Advisors’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Buy
359,725
+263,095
+272% +$3.81M ﹤0.01% 2511
2026
Q1 		$1.34M Sell
96,630
-127,664
-57% -$1.75M ﹤0.01% 2786
2025
Q4 		$3.1M Sell
224,294
-16,337
-7% -$384K ﹤0.01% 2640
2025
Q3 		$5.88M Buy
240,631
+101,970
+74% +$2.48M ﹤0.01% 2494
2025
Q2 		$3.2M Buy
138,661
+121,711
+718% +$3.21M ﹤0.01% 2634
2025
Q1 		$460K Sell
16,950
-3,098
-15% -$117K ﹤0.01% 3014
2024
Q4 		$1.07M Sell
20,048
-324
-2% -$17.1K ﹤0.01% 2897
2024
Q3 		$926K Sell
20,372
-3,647
-15% -$159K ﹤0.01% 2925
2024
Q2 		$1M Buy
24,019
+8,422
+54% +$395K ﹤0.01% 2908
2024
Q1 		$587K Buy
+15,597
New +$340K ﹤0.01% 3017

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Dimensional Fund Advisors's JANX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Janux Therapeutics (JANX) stake by 272% in Q2 2026, buying an estimated $3.81M and bringing the position to 359,725 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Dimensional Fund Advisors first reported a position in JANX in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.88M in Q3 2025. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Dimensional Fund Advisors held 359,725 shares of Janux Therapeutics worth $5.53M as of Q2 2026.
  • Dimensional Fund Advisors bought 263,095 Janux Therapeutics shares in Q2 2026, an estimated $3.81M.
  • Janux Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2511 holding.
  • Dimensional Fund Advisors first reported a position in Janux Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Dimensional Fund Advisors's Janux Therapeutics position peaked at $5.88M in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.